FIND OUT IF YOU QUALIFY TO GET COMPENSATION
Here are some of the facts in Xarelto lawsuits:
In October 2012, a motion was filed in the federal court system to consolidate all Xarelto bleeding injury cases as part of multidistrict litigation (MDL). The U.S. Judicial Panel on Multidistrict Litigation (JPML) was asked to centralize the cases before U.S. District Judge David R. Herndon in the Southern District of Illinois. This consolidation will coordinate case oversight, eliminate repetitive discovery, avoid conflicting orders from various courts and ensure more efficient processing of the cases.
In February 2013, Virginia Stuntebeck was hospitalized with severe gastrointestinal bleeding after taking Xarelto. She filed a lawsuit against Bayer in Philadelphia Courts, alleging that Bayer and J&J did not provide sufficient warnings about the health complications. The complaint states that the company was aware of the side effects and should not have sold Xarelto.
In June 2014, Nancy Packard sued Janssen and Bayer on behalf of her husband, William, who died after taking Xarelto for 6 months. He needed the medication for atrial fibrillation but suffered bleeding in his brain, which physicians could not stop. The Xarelto lawsuit alleges that the drug companies failed to warn about the lack of an antidote.
In August 2014, Ruth McGowan filed a lawsuit on behalf of her father, Thomas Dunkley. He died after taking Xarelto to reduce the risk of stroke but had serious brain bleeding after taking Xarelto for approximately 1 month. The lawsuit accuses Janssen and Bayer of hiding information about the side effects and not running adequate tests.
In December 2014, Xarelto lawsuits were consolidated in MDL in the U.S. District Court for the Eastern District of Louisiana. Judge Eldon Fallon was expected to hear these cases between February and May 2017.
In January 2015, a 90-count lawsuit requested a settlement of $4.35 million for a patient who had uncontrollable and sudden bleeding after taking Xarelto. The complaint alleged that the drug company used misleading information when advertising the medication as safe and effective. Referring to clinical studies, the lawsuit documents claim that Bayer failed to warn the public about possible death. After its initial filing, the case was moved as a part of the MDL in the Eastern District of Louisiana under Judge Eldon Fallon.